AdvisorShares Pure US Cannabis ETF (MSOS) - Stock Analysis
Last updated: Dec 18, 2025
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Exceptional short-term price surge nearly doubling in one week on regulatory optimism regarding U.S. marijuana reclassification. Strong investor demand and breakout technical patterns support a hot idea for near-term tactical gains, though elevated volatility and sector concentration warrant cautious position sizing.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Description
This actively managed ETF invests, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of U.S. companies that derive at least 50% of their net revenue from marijuana and hemp, as well as derivatives that provide similar economic exposure. It will concentrate at least 25% of its holdings in the pharmaceuticals, biotechnology and life sciences industry group within the health care sector. The fund is non-diversified.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Dec 18 | Dec 25 | MSOS | AdvisorShares Pure US Cannabis ETF | Exceptional short-term price surge nearly doubling in one week on regulatory optimism regarding U.S. marijuana reclassification. Strong investor demand and breakout technical patterns support a hot idea for near-term tactical gains, though elevated volatility and sector concentration warrant cautious position sizing. | Closed | -2.9% |